FIELD: medicine.
SUBSTANCE: invention refers to a contrast agent for magnetic resonance tomography (MRT) which contains ferric oxide nanoparticles and a carrier made of microspheric porous cellulose of particle size 10-125 mcm and internal pore volume not less than 90% prepared by bedding of a neutral cellulose mixed with calcium rhodanate.
EFFECT: invention provides enhancing image contrast, improved effectiveness and high safety for a person been tested.
2 tbl, 3 dwg, 11 ex
Title | Year | Author | Number |
---|---|---|---|
CONTRAST AGENT FOR T AND/OR T MAGNETIC RESONANT SCANNING AND METHOD FOR PREPARING IT | 2011 |
|
RU2471502C1 |
MAGNETIC RESONANT AND X-RAY CONTRAST AGENT, AND METHOD FOR PREPARING IT | 2012 |
|
RU2497546C1 |
PREPARATION OF EXTREMELY SMALL AND UNIFORM-SIZED, IRON OXIDE-BASED PARAMAGNETIC OR PSEUDO-PARAMAGNETIC NANOPARTICLES AND MRI T1 CONTRAST AGENTS USING SAME | 2011 |
|
RU2540472C2 |
MAGNETIC RESONANT AND RADIOPAQUE CONTRAST AGENT BASED ON COMPLEX FERRIC OXIDE AND METHOD FOR PRODUCING THEREOF | 2009 |
|
RU2419454C1 |
NANOPARTICLE CONTAINING ITS MAGNETIC RESONANCE IMAGING CONTRAST AGENT AND LIGAND COMPOUND | 2018 |
|
RU2767430C2 |
METHOD FOR PREPARING A PREPARATION FOR DIAGNOSING NEW GROWTHS BY MAGNETIC RESONANCE IMAGING | 2019 |
|
RU2723894C1 |
PREPARATION FOR DIAGNOSING NEW GROWTHS BY MAGNETIC RESONANCE IMAGING | 2019 |
|
RU2723932C1 |
METHOD OF OBTAINING MAGHEMITE NANOPARTICLES AND SUPERPARAMAGNETIC POWDER COMPOSITION | 2013 |
|
RU2533487C2 |
METHOD FOR PRODUCTION OF LABELED CELL CULTURE | 2019 |
|
RU2751603C2 |
NANOCOMPOSITES BASED ON GADOLINIUM-CONTAINING COMPOUNDS FOR DIAGNOSIS, THERAPY, AND THERANOSTICS OF ONCOLOGICAL DISEASES OF THE BRAIN AND METHODS FOR PRODUCTION THEREOF | 2021 |
|
RU2778928C1 |
Authors
Dates
2012-10-27—Published
2011-06-08—Filed